New Zealand markets open in 7 hours 37 minutes

  • NZX 50

    10,958.81
    -59.81 (-0.54%)
     

  • NZD/USD

    0.6220
    -0.0019 (-0.30%)
     

  • ALL ORDS

    6,877.90
    -75.50 (-1.09%)
     

  • OIL

    113.65
    +1.89 (+1.69%)
     

  • GOLD

    1,820.20
    -1.00 (-0.05%)
     

Blepharitis Drugs in Development Pipeline Guide 2022 by Stages, Target, MoA, RoA, Molecule Type and Key Players - ResearchAndMarkets.com

·4-min read

DUBLIN, May 19, 2022--(BUSINESS WIRE)--The "Blepharitis Drugs in Development 2022 Update" report has been added to ResearchAndMarkets.com's offering.

The pipeline guide provides comprehensive information on the therapeutics under development for Blepharitis (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The guide also reviews of key players involved in therapeutic development for Blepharitis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 1, 4, 1, 7 and 2 respectively.

The guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The guide is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Report Scope:

  • The pipeline guide provides a snapshot of the global therapeutic landscape of Blepharitis.

  • The pipeline guide reviews pipeline therapeutics for Blepharitis by companies and universities/research institutes based on information derived from company and industry-specific sources.

  • The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

  • The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

  • The pipeline guide reviews key companies involved in Blepharitis therapeutics and enlists all their major and minor projects.

  • The pipeline guide evaluates Blepharitis therapeutics based on mechanism of action, drug target, route of administration (RoA) and molecule type.

  • The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

  • The pipeline guide reviews latest news related to pipeline therapeutics for Blepharitis

Key Topics Covered:

Blepharitis - Overview

Therapeutics Development

  • Pipeline Overview

  • Pipeline by Companies

  • Products under Development by Companies

Therapeutics Assessment

  • Assessment by Target

  • Assessment by Mechanism of Action

  • Assessment by Route of Administration

  • Assessment by Molecule Type

Companies Involved in Therapeutics Development

Drug Profiles

Dormant Projects

Product Development Milestones

Featured News & Press Releases

  • Feb 08, 2022: Tarsus to host eye care leaders webcast on unmet needs in demodex blepharitis and potential of TP-03

  • Feb 02, 2022: Tarsus Completes enrollment for the pivotal phase 3 Saturn-2 trial of TP-03 to treat demodex blepharitis and secures $175 million credit facility

  • Nov 30, 2021: Nicox's positive post hoc results from NCX 4251 phase 2b Mississippi trial suggest path forward in dry eye disease

  • Nov 17, 2021: Nicox is granted patent for blepharitis product candidate NCX 4251 in Europe

  • Nov 04, 2021: Tarsus Pharmaceuticals, presents data from two pioneering studies on the prevalence and impact of Demodex Blepharitis at the American Academy of Optometry 2021 Annual Meeting

  • Aug 31, 2021: AxeroVision announces phase 2 results for AXR-270 for treatment of dry eye disease associated with MGD

  • Jul 24, 2021: Tarsus Pharmaceuticals presents new Saturn-1 pivotal trial data and Titan real-world prevalence study results at ASCRS 2021

  • Jul 02, 2021: Nicox announces last patient completed NCX 4251 Mississippi phase 2b blepharitis trial

  • Jun 21, 2021: Tarsus Pharmaceuticals announces positive results of Saturn-1 pivotal trial evaluating TP-03 for the treatment of demodex blepharitis

  • Jun 18, 2021: Tarsus Pharmaceuticals schedules conference call and webcast to announce saturn-1 phase 2b/3 pivotal trial results for TP-03 for the treatment of Demodex Blepharitis

  • Jun 01, 2021: Nicox's completes pre-defined enrollment of NCX 4251 Mississippi phase 2b Blepharitis trial

  • May 06, 2021: Tarsus Pharmaceuticals initiates Saturn-2, second pivotal phase 3 trial evaluating the safety and efficacy of TP-03 for the treatment of Demodex blepharitis

  • May 03, 2021: Tarsus Pharmaceuticals presents results of pioneering Atlas study at ARVO 2021 annual meeting demonstrating the functional and psychosocial impact of demodex blepharitis

  • Apr 23, 2021: Nicox's NCX 4251 Mississippi Phase 2b blepharitis trial reaches 50% enrollment

  • Mar 17, 2021: Hovione completes its Phase 2 clinical trial of the first minocycline ophthalmic showing promise in Dry Eye Disease associated with Inflamed Meibomian Gland Dysfunction

Companies Mentioned

  • Aerie Pharmaceuticals Inc

  • Aperta Biosciences LLC

  • AxeroVision Inc

  • Azura Ophthalmics Pty Ltd

  • Formosa Pharmaceuticals Inc

  • Hovione FarmaCiencia SA

  • Merck & Co Inc

  • NicOx SA

  • NTC srl

  • Premark Pharma GmbH

  • Quorum Innovations LLC

  • Santen Pharmaceutical Co Ltd

  • Sol-Gel Technologies Ltd

  • Tarsus Pharmaceuticals Inc

For more information about this report visit https://www.researchandmarkets.com/r/kgz0gj

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220519005528/en/

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting

Latest stories

  • Citizens Launches Workforce Development Support for Queens

    NEW YORK, June 29, 2022--Residents and businesses in Queens will benefit from broader and more equitable access to job training and development programs under a $350,000 Workforce Development programming commitment announced today by Citizens. The new initiative, launched in partnership with Pursuit, Rockaway Development & Revitalization Corporation, and Ocean Bay Community Development Corporation, will focus on much-needed technical skills training and career counseling in Queens.

  • SCOTUS Limits 2020 Ruling On Tribal Lands In Oklahoma

    Oklahoma can now prosecute non-Native Americans for crimes committed on tribal land.

  • Stocks Drop, Bonds Gain With Focus on Policy: Markets Wrap

    (Bloomberg) -- Stocks dropped while bonds gained, with traders assessing comments from major central bank chiefs for clues on the outlook for policy and the global economy.Most Read from BloombergRussia Slips Into Historic Default as Sanctions Muddy Next StepsTesla Cuts 200 Autopilot Workers as California Site ClosesBig Tech Sinks Stocks Bruised by Recession Jitters: Markets WrapTrump’s Final Scene Didn’t Go According to ScriptChina Cuts Travel Quarantine in Biggest Covid Zero Shift YetThe S&P 5

  • Fired Starbucks barista on labor agency move: 'It's exciting to see'

    The National Labor Relations Board is asking a federal court to issue Starbucks a "nationwide cease and desist order" over the firing of seven Starbucks employees in Buffalo, New York.

  • 79North Announces Non-Brokered Private Placement for Up to $700,000

    NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, June 29, 2022 (GLOBE NEWSWIRE) -- 79North Inc. (CSE: JQ; OTCQB: SVNTF; FRA: 6120) (“79North” or the “Company”) is pleased to announce a non-brokered private placement of up to 14,000,000 units of the Company (the "Units") at a price of $0.05 per Unit for aggregate gross proceeds of up to $700,000 (the "Offeri

  • Portfolio Update - Exit - Sale of portfolio company TFC Europe Limited

    Foresight Enterprise VCT PLC LEI: 213800MWJNR3WZZ3ZP42 Exit: Sale of portfolio company TFC Europe to AFC Industries delivers 12.6x cash-on-cash return for Foresight Enterprise VCT and other funds managed by Foresight Group The Board of Foresight Enterprise VCT Plc (the “Company”) is pleased to announce the successful sale on 29 June 2022 of portfolio company TFC Europe Limited (“TFC”), a leading European supplier of technical fasteners and wave springs, to AFC Industries Inc. (“AFC”), which prov

  • NATO formally invites Sweden and Finland to join alliance after Turkey lifts objections

    NATO on Wednesday formally invited Finland and Sweden to join the military alliance after Turkey dropped its objections this week.

  • Fortune Minerals Announces Results of Annual General Meeting of Shareholders

    LONDON, Ontario, June 29, 2022--Fortune Minerals Limited (TSX: FT) (OTCQB: FTMDF) ("Fortune" or the "Company") (www.fortuneminerals.com) reports that the nominees listed in the management information circular for the 2022 Annual General Meeting of shareholders held on June 28, 2022 (the "Meeting") were elected as directors of Fortune. Detailed results of the vote based on proxies received are set out below:

  • Helbiz Expands its Micro-mobility Operations Across U.S. Markets

    NEW YORK, June 29, 2022--Helbiz, Inc. (Nasdaq: HLBZ), is expanding its micro-mobility operations in the U.S. Tampa, Florida will join Helbiz’s growing roster of U.S. cities and the company will expand its fleets in Flint, Michigan and Miami Lakes, Florida.

  • Kraft Heinz Inks Deal with BHE Renewables to Invest in Renewable Energy to Help Power U.S. Operations

    PITTSBURGH & CHICAGO, June 29, 2022--The Kraft Heinz Company (Nasdaq: KHC) ("Kraft Heinz" or the "Company") today announced a virtual power purchase agreement ("vPPA") with BHE Renewables, a Berkshire Hathaway Energy business, for its operations within the United States, which make up the largest part of the Company’s North America Zone. This agreement is designed to enable Kraft Heinz to achieve its aspiration of procuring the majority of its electricity from renewable sources by 2025, a key fo

  • The Global Laser Processing Market size is expected to reach $31.4 billion by 2028, rising at a market growth of 9.2% CAGR during the forecast period

    Laser processing, is a procedure used for laser irradiation, laser cutting, surface modification, laser engraving, laser drilling, and micro processing, is the application of a laser beam to the surface of a material to complete the processing.New York, June 29, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Laser Processing Market Size, Share & Industry Trends Analysis Report By Process, By Application, By Product, By Regional Outlook and Forecast, 2022 –

  • CN Ranked as one of Canada’s Best 50 Corporate Citizens by Corporate Knights

    MONTREAL, June 29, 2022 (GLOBE NEWSWIRE) -- For the fourteenth consecutive year, CN (TSX: CNR) (NYSE: CNI) has earned a place on the Corporate Knights Best 50 Corporate Citizens list. “We are pleased to have made the top 50 Best Corporate Citizens list. CN believes in Delivering Responsibly. This means moving our customers’ goods safely and efficiently, ensuring we deliver in an environmentally responsible manner; attracting, developing, and retaining top diverse talent; helping to make the comm

  • 3 Stocks Smart Investors Are Buying Right Now

    A Buffett stock pick and two from a star hedge fund manager make up a strong list of stock candidates.

  • ePharmacy Market Size to Worth Around US$ 256 Billion by 2030

    As per Precedence Research, the global ePharmacy market was valued at US$ 59.93 billion in 2021 and is expected to worth around US$ 256 billion by 2030 with a CAGR of 17.51% from 2022 to 2030.Ottawa, June 29, 2022 (GLOBE NEWSWIRE) -- The rapidly growing geriatric population, rising penetration of e-commerce, rising prevalence of diseases, and rapidly growing adoption of the digital technologies across the globe are the most prominent factors that are driving the growth of the global ePharmacy ma

  • The Challenge: USA Host TJ Lavin Makes His Grand Entrance and Gives Cast $1,000 Each in Sneak Peek

    Plus: Love Island's Cashay Proudfoot serves "the tea" on her relationship with Cinco Holland Jr.

  • R. Kelly sentenced on sex trafficking and racketeering charges

    Singer R. Kelly is sentenced in a federal courthouse in New York after being found guilty of sex trafficking and racketeering charges in September of last year.

  • FCC commissioner asks Apple and Google to remove TIkTok

    Yahoo Finance’s Dan Howley joins the Live show to discuss the FCC urging Apple and Google to remove TikTok from their app stores amid growing worries of U.S. user data being accessed by China.

  • Primaris REIT Announces Financial Results Release Date, Webcast, and Conference Call

    TORONTO, June 29, 2022--Primaris Real Estate Investment Trust ("Primaris" or the "Trust") (TSX: PMZ.UN) will be releasing its financial results for the quarter ended June 30, 2022, on Wednesday, August 3, 2022, after the market closes. Senior leadership will be hosting a conference call, webcast and presentation on August 4, 2022.

  • The Global Laundry Care Market size is expected to reach $126 billion by 2028, rising at a market growth of 3.9% CAGR during the forecast period

    Fabric wash and care products are used to keep garments from deteriorating due to normal washing and use. These things are also utilized for cleaning in a variety of industries, including automotive and aviation.New York, June 29, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Laundry Care Market Size, Share & Industry Trends Analysis Report By Product Type, By Distribution Channel, By Regional Outlook and Forecast, 2022 – 2028" - https://www.reportlinker.c

  • Form 8.3 - MGGT LN Equity 28-June-22 Dealing Disclosure

    LONDON, June 29, 2022-- FORM 8.3